What I offer
Behavioural Science Consulting
Why don’t patients adhere? Why do HCPs hesitate to adopt or prescribe? How do payers decide? Let’s find out what’s going on and tackle it together.
Learn more
Strategic Insights Consulting
Good research should do more than just sit in a report. It should shape smart decisions. I help pharma, medtech, and life science companies and consultancies turn insights into action, making sure research leads to tangible impact.
Experiences
Brand & Growth Strategy – Dental MedTech
Defined brand positioning and growth drivers for a dental aligner brand. Used provider insights to uncover switching behaviour and emotional loyalty. Supported commercial, CX, and training strategy in a crowded market.
Global Innovation Strategy – Hypertension
Led unmet needs assessment and whitespace mapping for fixed-dose combinations in hypertension. Combined qual, quant, and KOL input to inform cross-market opportunity framing and guide innovation decisions.
Behaviour Change – Type 2 Diabetes
Explored psychological insulin resistance and drivers of patient reluctance to start insulin. Applied behavioural frameworks to identify emotional barriers and recommend interventions to improve uptake and self-management.
MedTech Launch Strategy – Nephrology
Developed launch positioning and messaging for a niche nephrology device. Mapped unmet needs among clinicians and hospital stakeholders. Delivered brand book and strategy to align sales, marketing, and medical teams.
Strategic Audience Segmentation – Migraine
Led HCP and patient segmentation across European markets for a novel preventative migraine therapy. Insights shaped messaging, education tools, and rollout strategy to accelerate adoption and access.
Patient Experience – Oncology
Explored patient journey and touchpoints to improve experience for a cancer therapy. Identified emotional and practical pain points, enabling the client to optimise support, comms, and care delivery pathways.
Behavioural Insights – Migraine Pre-Launch
Analysed existing data to identify hidden barriers to adoption of a new preventative migraine therapy. Used behavioural frameworks to uncover implicit drivers and inform pre-launch strategies to support uptake.
